File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

유자형

Ryu, Ja-Hyoung
Supramolecular Nanomaterials Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Intracellular stimulus responsive non-covalent peptide gatekeepers in hallow mesoporous silica platform for targeted drug delivery

Author(s)
Oh, JunyongPalanikumar, LRyu, Ja-Hyoung
Issued Date
2015-04-15
URI
https://scholarworks.unist.ac.kr/handle/201301/42173
Fulltext
https://kcsnet.or.kr/?mid=abstract_view&uid=30581&page=29&qpage=&word=&wordfield=partnum&main_number=115
Citation
115th Annual Meeting of Korean Chemical Society
Abstract
Among the drug delivery carriers, gatekeepers in mesoporous silica nanoparticles have received much attention in multifunctional targeted drug delivery system due to their tunable pore morphology, high specific surface area, easy surface modification/ bioconjugation for targeting and physiochemical stability. One among them was hollow mesoporous silica nanoparticles. Since they can host the therapeutic compounds that are easily degraded in the hostile biological environment; delivered per se without encapsulation and their void cores can serve as a extra reservoirs for the drug storage. In the present work, we develop a biocompatible and stable carrier for anticancer drug delivery using the noncovalent peptide gatekeeper technique. The drug loaded nanoparticles were wrapped with glutathione s-transferase Z domain peptide. Further this peptide can be decorated with several types of antibody and epibodies to target the cancer cells. Upon its internalization, the drug can be released inside the cell due to the increased intracellular glutathione concentration. Keywords: Glutathione; GST-Z domain; Epibody; Antibody; peptide gatekeepers; mesoporous silica nanoparticles.
Publisher
대한화학회

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.